Published in PLoS One on February 16, 2010
Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06
Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 2.36
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest (2013) 2.34
Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells (2010) 1.98
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66
Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells (2012) 1.59
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol (2013) 1.47
Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment. PLoS One (2016) 1.39
Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem (2012) 1.33
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells (2014) 1.29
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med (2014) 1.26
New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther (2010) 1.24
The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol (2011) 1.16
Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PLoS One (2012) 1.14
Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab (2013) 1.13
Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res Ther (2013) 1.12
Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev (2014) 1.10
Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. PLoS One (2012) 1.10
Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells. J Dent Res (2012) 1.09
Mesenchymal stromal cells: a key player in 'innate tolerance'? Immunology (2012) 1.07
Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal (2012) 1.06
Mesenchymal stem cell-educated macrophages. Transplant Res (2012) 1.00
High-resolution in-vivo analysis of normal brain response to cranial irradiation. PLoS One (2012) 1.00
Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol (2011) 1.00
Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res (2011) 0.98
Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. Am J Respir Crit Care Med (2015) 0.97
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology (2014) 0.94
Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Leuk Lymphoma (2013) 0.93
Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. Stem Cells Transl Med (2012) 0.92
Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. Mediators Inflamm (2013) 0.91
Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med (2013) 0.90
New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells (2015) 0.90
CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells. PLoS One (2012) 0.89
Bone marrow-derived mesenchymal stromal cells enhance chimeric vessel development driven by endothelial cell-coated microtissues. Tissue Eng Part A (2011) 0.88
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy (2012) 0.88
The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells. J Mol Histol (2014) 0.88
Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther (2016) 0.88
Mesenchymal Stem Cell Therapy for Cutaneous Wounds. Adv Wound Care (New Rochelle) (2012) 0.87
Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Expert Rev Neurother (2011) 0.87
Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell (2014) 0.87
The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair. Int J Mol Sci (2013) 0.87
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther (2016) 0.86
The Role of Mesenchymal Stem Cells in the Regenerative Wound Healing Phenotype. Adv Wound Care (New Rochelle) (2012) 0.86
Stromal cells in tissue homeostasis: balancing regeneration and fibrosis. Nat Rev Nephrol (2013) 0.86
Inflammation, fracture and bone repair. Bone (2016) 0.85
In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. Stem Cells Dev (2013) 0.85
Enhanced medial collateral ligament healing using mesenchymal stem cells: dosage effects on cellular response and cytokine profile. Stem Cell Rev (2014) 0.84
Are mesenchymal stromal cells immune cells? Arthritis Res Ther (2015) 0.83
Topographical cues regulate the crosstalk between MSCs and macrophages. Biomaterials (2014) 0.83
CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human. PLoS One (2013) 0.83
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. J Immunol Res (2015) 0.83
Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B. J Tissue Sci Eng (2011) 0.82
14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury. Stem Cells Dev (2011) 0.82
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. Leukemia (2015) 0.82
Cancer-associated mesenchymal stem cells aggravate tumor progression. Front Cell Dev Biol (2015) 0.82
Interactions between MSCs and immune cells: implications for bone healing. J Immunol Res (2015) 0.81
Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells Int (2012) 0.81
Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function. Stem Cells Transl Med (2015) 0.81
Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy. Cell Mol Neurobiol (2016) 0.80
Microglia differentiation using a culture system for the expansion of mice non-adherent bone marrow stem cells. J Inflamm (Lond) (2012) 0.80
Replenishing B lymphocytes in health and disease. Curr Opin Immunol (2012) 0.80
Mesenchymal stem cell therapy in osteoarthritis: advanced tissue repair or intervention with smouldering synovial activation? Arthritis Res Ther (2013) 0.80
Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int (2013) 0.80
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy. Front Immunol (2016) 0.79
Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med (2016) 0.79
Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol (2012) 0.79
Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions. Stem Cell Res Ther (2015) 0.78
Complement activation in the context of stem cells and tissue repair. World J Stem Cells (2015) 0.78
Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells Int (2015) 0.78
Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced Systemic Response. Mediators Inflamm (2016) 0.78
Characterization of adipose-derived stromal/stem cells from the Twitcher mouse model of Krabbe disease. BMC Cell Biol (2013) 0.78
Transplanted Human Bone Marrow Mesenchymal Stem Cells Seeded onto Peptide Hydrogel Decrease Alveolar Bone Loss. Biores Open Access (2012) 0.78
Bone marrow stromal cells as immunomodulators. A primer for dermatologists. J Dermatol Sci (2014) 0.78
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies. Neural Regen Res (2016) 0.77
The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem Cells Transl Med (2015) 0.77
Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. PLoS One (2013) 0.77
Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? World J Stem Cells (2015) 0.77
The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p. Stem Cell Res Ther (2014) 0.77
MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant. PLoS One (2014) 0.77
Mesenchymal stem cells in transplantation and tissue regeneration. Front Immunol (2011) 0.77
Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts. Stem Cells Int (2014) 0.77
Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing of corneal alkali burn in rats. PLoS One (2015) 0.77
Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis (2016) 0.76
Morphology and size of stem cells from mouse and whale: observational study. BMJ (2013) 0.76
Therapeutic use of stem cells for cardiovascular disease. Clin Transl Med (2016) 0.76
Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. Int J Parasitol Drugs Drug Resist (2015) 0.76
The influence of macrophages on mesenchymal stromal cell therapy: Passive or aggressive agents? Clin Exp Immunol (2017) 0.76
Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts. Stem Cells Dev (2015) 0.76
Unique regulatory properties of mesangial cells are genetically determined in the rat. PLoS One (2014) 0.75
Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells. Stem Cell Res Ther (2016) 0.75
Engineered composite fascia for stem cell therapy in tissue repair applications. Acta Biomater (2015) 0.75
Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells. Front Immunol (2015) 0.75
Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment. Cancer Immunol Immunother (2015) 0.75
Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease. Stem Cells Int (2016) 0.75
Stem cell conditioned culture media attenuated albumin-induced epithelial-mesenchymal transition in renal tubular cells. Cell Physiol Biochem (2015) 0.75
The Effect of Adipose-Derived Stem Cells on Full-Thickness Skin Grafts. Biomed Res Int (2016) 0.75
Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth. Stem Cells Transl Med (2016) 0.75
Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation. Sci Rep (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2003) 12.34
Origin and physiological roles of inflammation. Nature (2008) 11.68
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (2007) 8.64
Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97
The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol (1993) 5.88
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol (2007) 5.83
Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol (2007) 5.66
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2002) 5.14
Human mesenchymal stem cells modulate B-cell functions. Blood (2005) 5.12
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07
Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol (2007) 4.93
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 4.10
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood (2007) 3.38
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica (2005) 3.11
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 3.07
Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol (2006) 3.00
Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med (1998) 2.89
Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol (1995) 2.57
Clearance of apoptotic cells by phagocytes. Cell Death Differ (2007) 2.53
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation (2003) 2.49
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol (2007) 2.45
Alternatively activated macrophages in helminth infections. Curr Opin Immunol (2007) 2.41
IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol (2001) 2.13
Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol (2006) 1.94
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 1.89
Mesenchymal stromal cells. Curr Opin Hematol (2006) 1.88
Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation (2007) 1.83
Postnatal skeletal stem cells. Methods Enzymol (2006) 1.62
IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol (1997) 1.61
Production of interferon-gamma by myeloid cells--fact or fancy? Trends Immunol (2006) 1.55
Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol (2004) 1.49
A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J Immunol (2007) 1.46
Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood (2004) 1.44
An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol (2006) 1.43
Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells (2008) 1.42
Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J Immunol (1998) 1.41
Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology (2008) 1.35
Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol (2008) 1.29
Potential of mesenchymal stem cell therapy. Curr Opin Oncol (2007) 1.14
How do mesenchymal stromal cells suppress T cells? Cell Stem Cell (2008) 1.08
Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J Leukoc Biol (2002) 1.06
[Isolation of a Trypanosoma cruzi strain of predominantly slender form in Argentina]. Medicina (B Aires) (1981) 1.03
Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun (2006) 1.02
The IL-12 p40 homodimer as a specific antagonist of the IL-12 heterodimer. Immunol Today (1995) 0.93
Experimental Chagas' disease: electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myotropic and a pantropic strain of Trypanosoma cruzi. Clin Immunol Immunopathol (1994) 0.87
Differences in the inducible gene expression and protein production of IL-12p40, IL-12p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine (2008) 0.81
[Experimental study on influence of bone marrow mesenchymal stem cells on activation and function of mouse peritoneal macrophages]. Zhonghua Xue Ye Xue Za Zhi (2008) 0.80
NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood (2008) 2.54
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol (2009) 2.23
Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J Immunol (2005) 2.21
Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med (2009) 1.24
Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol (2007) 1.23
Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol (2004) 1.23
Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways. J Immunol (2006) 1.19
Extracellular DNA: a major proinflammatory component of Pseudomonas aeruginosa biofilms. J Immunol (2010) 1.12
Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol (2004) 1.10
Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J Virol (2007) 1.09
Control of dendritic cell differentiation by angiotensin II. FASEB J (2003) 1.04
Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res (2007) 1.04
Detection of human mammary tumor virus proteins in human breast cancer cells. J Virol Methods (2009) 1.02
Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function. Cytokine Growth Factor Rev (2007) 1.02
Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur J Immunol (2003) 1.00
Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol (2006) 0.99
Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol (2007) 0.99
Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J Immunol (2005) 0.93
Toddaculin, a natural coumarin from Toddalia asiatica, induces differentiation and apoptosis in U-937 leukemic cells. Phytomedicine (2012) 0.90
Histamine improves antigen uptake and cross-presentation by dendritic cells. J Immunol (2007) 0.89
Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pretreatment. FEMS Immunol Med Microbiol (2004) 0.87
Flagellin delays spontaneous human neutrophil apoptosis. Lab Invest (2010) 0.87
Cholinergic modulation of dendritic cell function. J Neuroimmunol (2011) 0.85
Analysis of the mechanisms involved in the stimulation of neutrophil apoptosis by tumour necrosis factor-alpha. Immunology (2004) 0.85
The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes. J Virol (2007) 0.85
Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia. J Immunol (2008) 0.84
Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther (2002) 0.84
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors. Cancer Immunol Immunother (2007) 0.83
Neutrophil signaling pathways activated by bacterial DNA stimulation. J Immunol (2006) 0.83
Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Breast Cancer Res Treat (2002) 0.83
Host response to respiratory syncytial virus infection. Curr Opin Infect Dis (2015) 0.82
Characterization of bacterial DNA binding to human neutrophil surface. Lab Invest (2008) 0.82
NADPH oxidase derived reactive oxygen species are involved in human neutrophil IL-1β secretion but not in inflammasome activation. Eur J Immunol (2013) 0.82
Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. Biochem Pharmacol (2007) 0.82
Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection. J Virol (2008) 0.81
Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes. Eur J Immunol (2002) 0.81
SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression. Br J Haematol (2007) 0.81
Histamine-treated dendritic cells improve recruitment of type 2 CD8 T cells in the lungs of allergic mice. Immunology (2010) 0.81
Human platelets produce granulocyte-macrophage colony-stimulating factor and delay eosinophil apoptosis. Lab Invest (2003) 0.80
[L-selectin expression on T lymphocytes and neutrophils in HIV infected children]. Medicina (B Aires) (2005) 0.80
Thioperamide induces CD4 CD25 Foxp3 regulatory T lymphocytes in the lung mucosa of allergic mice through its action on dendritic cells. J Asthma Allergy (2011) 0.79
Regulation of neutrophil apoptosis by cytokines, pathogens and environmental stressors. Front Biosci (Landmark Ed) (2009) 0.79
Angiotensin II type 1a-deficient bone marrow-derived dendritic cells produce higher levels of monocyte chemoattractant protein 1. Hypertension (2010) 0.79
Expression of Fcgamma receptors type II (FcgammaRII) in chronic lymphocytic leukemia B cells. Blood (2003) 0.79
Tumor transition zone: a putative new morphological and functional hallmark of tumor aggressiveness. Oncol Res (2005) 0.79
Macrophage depletion following liposomal-encapsulated clodronate (LIP-CLOD) injection enhances megakaryocytopoietic and thrombopoietic activities in mice. Br J Haematol (2003) 0.78
Leukotriene C(4) prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance. Immunology (2011) 0.78
GM-CSF enhances a CpG-independent pathway of neutrophil activation triggered by bacterial DNA. Mol Immunol (2008) 0.78
AT1 receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system. FASEB J (2012) 0.78
Uptake and intracellular trafficking of superantigens in dendritic cells. PLoS One (2013) 0.77
Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma. Cancer Immunol Immunother (2010) 0.77
[Regulatory T cell depletion increases the number of CD8 cells during mouse mammary tumor virus infection]. Medicina (B Aires) (2011) 0.77
Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12. Immunology (2007) 0.77
Superantigens increase the survival of mice bearing T cell lymphomas by inducing apoptosis of neoplastic cells. PLoS One (2010) 0.77
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action. Bioorg Med Chem (2012) 0.77
Immune complexes and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma (2002) 0.76
B-cell lymphopoiesis is regulated by cathepsin L. PLoS One (2013) 0.76
Pharmacodynamic study of the 7,8-dihydroxy-4-methylcoumarin-induced selective cytotoxicity toward U-937 leukemic cells versus mature monocytes: cytoplasmic p21(Cip1/WAF1) as resistance factor. Biochem Pharmacol (2013) 0.76
Stimulation of neutrophil apoptosis by immobilized IgA. J Leukoc Biol (2002) 0.75
Response to comment on "Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number". J Immunol (2006) 0.75
Epithelial cells activate plasmacytoid dendritic cells improving their anti-HIV activity. PLoS One (2011) 0.75
Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response. J Gen Virol (2010) 0.75
[Increase of regulatory T cells in the lymph node of cathepsin L mutant mice]. Medicina (B Aires) (2011) 0.75
[Nobel Prize in Medicine in immunology: dendritic cells and the renaissance of innate immunity]. Medicina (B Aires) (2011) 0.75